Needham & Company LLC Boosts Endava (NYSE:DAVA) Price Target to $43.00

Endava (NYSE:DAVAFree Report) had its price objective lifted by Needham & Company LLC from $36.00 to $43.00 in a report published on Friday morning,Benzinga reports. Needham & Company LLC currently has a buy rating on the stock.

Several other analysts have also issued reports on DAVA. Citigroup cut their price target on shares of Endava from $30.00 to $27.00 and set a “neutral” rating for the company in a research report on Monday, October 28th. Susquehanna reduced their price target on Endava from $66.00 to $55.00 and set a “positive” rating on the stock in a research report on Friday, September 20th. TD Cowen boosted their price objective on Endava from $35.00 to $36.00 and gave the company a “buy” rating in a research report on Wednesday, November 13th. Bank of America started coverage on shares of Endava in a report on Friday, November 22nd. They issued a “neutral” rating and a $29.00 target price on the stock. Finally, Guggenheim lowered their price target on shares of Endava from $45.00 to $40.00 and set a “buy” rating for the company in a report on Wednesday, November 6th. Four analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $40.46.

Get Our Latest Stock Report on DAVA

Endava Price Performance

Shares of Endava stock opened at $31.25 on Friday. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.90 and a current ratio of 1.90. Endava has a 52-week low of $23.28 and a 52-week high of $81.06. The company has a fifty day moving average of $29.03 and a 200-day moving average of $28.86. The stock has a market capitalization of $1.84 billion, a price-to-earnings ratio of 223.21, a price-to-earnings-growth ratio of 2.16 and a beta of 1.22.

Institutional Investors Weigh In On Endava

Several hedge funds have recently made changes to their positions in DAVA. GAMMA Investing LLC lifted its position in Endava by 86.4% during the fourth quarter. GAMMA Investing LLC now owns 1,607 shares of the company’s stock valued at $50,000 after buying an additional 745 shares during the period. 272 Capital LP lifted its position in Endava by 156.3% during the 3rd quarter. 272 Capital LP now owns 145,146 shares of the company’s stock valued at $3,707,000 after acquiring an additional 88,518 shares during the period. DF Dent & Co. Inc. boosted its stake in Endava by 2.5% during the third quarter. DF Dent & Co. Inc. now owns 777,108 shares of the company’s stock worth $19,847,000 after acquiring an additional 18,882 shares in the last quarter. State Street Corp grew its holdings in Endava by 33.0% in the third quarter. State Street Corp now owns 80,148 shares of the company’s stock worth $2,047,000 after purchasing an additional 19,884 shares during the period. Finally, HighTower Advisors LLC grew its holdings in Endava by 11.7% in the third quarter. HighTower Advisors LLC now owns 15,143 shares of the company’s stock worth $390,000 after purchasing an additional 1,592 shares during the period. 62.23% of the stock is currently owned by institutional investors.

Endava Company Profile

(Get Free Report)

Endava plc provides technology services for clients in the consumer products, healthcare, mobility, and retail verticals in North America, Europe, the United Kingdom, and internationally. It offers ideation and production services in the payments and financial services, telecommunications, media, and technology verticals; and business analysis, data analytics, program management, digital product strategy, private equity value enhancement, IT strategy, architecture, extended reality, machine learning and artificial intelligence, product design, and user experience and visual design services.

Recommended Stories

Analyst Recommendations for Endava (NYSE:DAVA)

Receive News & Ratings for Endava Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Endava and related companies with MarketBeat.com's FREE daily email newsletter.